One of the few silver bullets we have to meet the SDGs is digitalization. We need governments to unleash its potential faster. Digitalization is something industries and governments of all stripes can rally around.
Though the embrace of digitalization and data analytics have made companies significantly more efficient and informed, it has also made them more vulnerable to cyberattacks.
In recognition of Earth Day, our Bangalore team planted a variety of trees including yellow cannas, ficus ponda, hibiscus edging, dracaena and crape myrtle!
Always, the leader in global menstrual care, and International Paper, the leading global supplier of renewable fiber-based products, are partnering to drive systemic solutions to help End Period Poverty.
When FedEx representatives heard on a conference call that the American Red Cross was aiming to increase the number of African American blood donors by the end of 2025, the company realized it was well-positioned to help.
More than 19,000 employees at Fifth Third Bank are helping to provide 5.3 million meals in May to people facing food insecurity.
Southern-based non-profit Women’s Foundation of the South (WFS) is pleased to announce that it is airing the first episode of its four-part Learn with Us series on streaming service Vimeo.
My Possibilities completed phase one of their capital campaign for the construction of two buildings on the Campus for Higher Learning. Bread financial, formerly Alliance Data, and the Rees-Jones Foundation contributed to the capital campaign.
The global pandemic disrupted business operations and exposed supply chains that were fine-tuned for efficiency but not resilience. Today, the war in Ukraine and the recent lockdowns in China have again put entire value chains under stress.
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight™ Oncology (TSO) Comprehensive (EU) test. This single test kit, recently launched across Europe, assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient's cancer.